Gene · 7030
Papers3,398
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,398
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antioxidant Potential of Exosomes in Animal Nutrition. | Antioxidants (Basel) | 2024 | 39199210 | PubTator, text mining | PubMed |
| TFE3-rearranged nonmelanotic renal PEComa: a case series expanding their phenotypic and fusion landscape. | Histopathology | 2024 | 39169706 | PubTator, text mining | PubMed |
| A genetic basis for sex differences in Xp11 translocation renal cell carcinoma. | Cell | 2024 | 39168126 | PubTator, text mining | PubMed |
| TFE3 fusions direct an oncogenic transcriptional program that drives OXPHOS and unveils vulnerabilities in translocation renal cell carcinoma. | bioRxiv | 2024 | 39149323 | PubTator, text mining | PubMed |
| CDK4/6 Inhibitors Impede Chemoresistance and Inhibit Tumor Growth of Small Cell Lung Cancer. | Adv Sci (Weinh) | 2024 | 39136283 | PubTator, text mining | PubMed |
| The Clinicopathological Characteristics and Prognosis of 55 Patients With TFE3-Rearranged Renal Cell Carcinomas. | Clin Genitourin Cancer | 2024 | 39111254 | PubTator, text mining | PubMed |
| PDCD4 triggers α-synuclein accumulation and motor deficits via co-suppressing TFE3 and TFEB translation in a model of Parkinson's disease. | NPJ Parkinsons Dis | 2024 | 39107320 | PubTator, text mining | PubMed |
| [Primary malignant perivascular epithelioid cell tumors with TFE3 rearrangement of bone: a clinicopathological analysis of two cases]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 39103270 | PubTator, text mining | PubMed |
| [TFE3-rearranged perivascular epithelioid cell tumors: a clinicopathological analysis of eight cases]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 39103264 | PubTator, text mining | PubMed |
| [Clinicopathological features of BAP1 mutated clear cell renal cell carcinoma]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 39103260 | PubTator, text mining | PubMed |
| NMRK2 is an efficient diagnostic indicator for Xp11.2 translocation renal cell carcinoma. | J Pathol | 2024 | 39092712 | PubTator, text mining | PubMed |
| Comprehensive molecular characterization of TFE3-rearranged renal cell carcinoma. | Exp Mol Med | 2024 | 39085357 | PubTator, text mining | PubMed |
| Efficacy and safety of nivolumab monotherapy in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (OSCAR Trial/NCCH1510). | Cancer | 2024 | 39077795 | PubTator, text mining | PubMed |
| Case report: Metastatic refractory undifferentiated small round-cell sarcoma successfully treated with surufatinib and camrelizumab. | Front Oncol | 2024 | 39055564 | PubTator, text mining | PubMed |
| Editorial: Case reports in PET imaging 2023. | Front Med (Lausanne) | 2024 | 39050545 | PubTator, text mining | PubMed |
| The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD. | Nat Commun | 2024 | 39034314 | PubTator, text mining | PubMed |
| The Spectrum of Renal "TFEopathies": Flipping the mTOR Switch in Renal Tumorigenesis. | Physiology (Bethesda) | 2024 | 39012319 | PubTator, text mining | PubMed |
| Pressure sensing of lysosomes enables control of TFEB responses in macrophages. | Nat Cell Biol | 2024 | 38997458 | PubTator, text mining | PubMed |
| Pregnant patient with Xp11.2/transcription factor E3 translocation renal cell carcinoma: a case report and literature review. | Front Oncol | 2024 | 38988705 | PubTator, text mining | PubMed |
| Unusual PEComa With PRCC :: TFE3 Fusion Mimicking Sinonasal Tract Melanoma. | Appl Immunohistochem Mol Morphol | 2024 | 38975712 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7030/papers?page=18